Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

2 Jun 2020 07:00

RNS Number : 5733O
Xaar PLC
02 June 2020
 

Xaar plc

 

Trading update 

 

 

At the Annual General Meeting ("AGM") held in Cambridge today, Andrew Herbert, Chairman of Xaar plc ("Xaar" or the "Group") will make the following statement:-

 

 

OPERATIONS

 

In responding to the challenges surrounding the COVID-19 pandemic, our priorities have been to safeguard the health and wellbeing of our colleagues, to maintain our business operations and to continue to serve our customers.

 

In March, when lockdown measures were introduced in the UK and elsewhere, we implemented safe working methods for all staff where their attendance on site was necessary, particularly in our factories, while other staff were able to work remotely. The whole team has demonstrated tremendous resilience in difficult circumstances and as a result the business has been able to operate efficiently and continue to meet its commitments to customers.

 

 

CURRENT TRADING AND OUTLOOK

 

Overall trading in the first four months of the new financial year has been in line with the expectation we established before the Covid-19 outbreak. Sales have been weaker in Europe and North America but stronger in Asia where economies have come out of lockdown sooner. Our short-term order book is healthy but the outlook for the second half of the year remains uncertain and it is too early to assess the impact of the pandemic on the results for the full year 2020 and into 2021.

 

The board will re-establish guidance on expectations as more economies emerge from lockdown and there is greater certainty surrounding economic conditions. We remain confident and focused on our medium-term strategy to return the business to profitability and growth.

 

 

BALANCE SHEET AND LIQUIDITY

 

The Group entered the year with a strong balance sheet and net cash and an appropriate level of funding to support its strategy. We have maintained disciplined cost control and strong cash management over the past four months and remain well positioned.

 

 

Enquiries:

 

Xaar plc

Ian Tichias, Chief Finance Officer

& Company Secretary

 

+44 (0) 1223 423 663 

John Mills, Chief Executive Officer

 

 

 

Tulchan Communications

 

 

 

+44 (0) 207 353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFLFBBQLZBBZ
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.